NSE · NURECA
Nureca Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,150
of 5,072 stocks
▲ 41W
Peak #2,150 · 27 Sep 2026
Nureca Limited, a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and has a subdued return on equity.
Market Cap
335.40 Cr
P/E Ratio
166.59
P/B Ratio
1.86
ROE
1.15%
ROCE
3.43%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 40.34 Cr | 35.40 Cr | 39.64 Cr | 37.74 Cr |
| Net Profit | 3.07 Cr | -6.09 Cr | 3.73 Cr | 3.63 Cr |
| EPS | 3.21 | -6.45 | 3.91 | 3.63 |
| Operating Profit | 4.63 Cr | -5.21 Cr | 4.94 Cr | 5.05 Cr |
Shareholding pattern
Promoter
68.09%
Public
31.91%
Mutual fund holdings
₹9.30
Cr total
2
Schemes
2
Fund Houses
₹9.30 Cr
Total Exposure
Quant Mutual Fund₹9.30 Cr (100.0%)
Motilal Oswal Mutual Fund₹0.00 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Dec 2025 | Buyback | Buy Back |
| 11 Jul 2024 | Other | Annual General Meeting |
| 13 Jul 2023 | Other | Annual General Meeting |
| 01 Sep 2022 | Other | Annual General Meeting |
| 13 Jul 2022 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.